Pinosylvin Inhibits Inflammatory and Osteoclastogenesis via NLRP3 Inflammasome
Advanced Science · 2025
DOI: 10.1002/advs.202501532 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Wei Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The First Affiliated Hospital of Soochow University, No. 188 Shizi Street, Suzhou, Jiangsu, 215006, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Osteogenesis, Inflammasomes, Osteoclasts. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Program of Suzhou Health Commission, National and Local Engineering Laboratory of New Functional Polymer Materials.
Abstract (Originalsprache)
Pro‐inflammatory cytokines such as TNF, IL‐1, and IL‐6 trigger aberrant osteoclastogenesis and result in massive bone loss. During RANKL‐induced osteoclastogenesis, pyroptosis of macrophages/preosteoclasts acts as a pivotal mechanism for IL‐1β release, thereby promoting osteoclast maturation and bone resorption. In the current study, it is observed that Pinosylvin (PIN), a compound extracted from European red pine, selectively inhibits LPS‐ and RANKL‐induced release of IL‐1β effectively reducing osteoclastogenesis. Notably, PIN inhibits the assembly of NLRP3 and the cleavage of GSDMD, pro‐IL‐1β, and pro‐caspase‐1, suggesting its therapeutic effects are NLRP3‐targeted. Mechanistically, PIN blockes the NEK7/NLRP3 interaction, but not the NLRP3/ASC interaction, through its 3,5‐dihydroxy groups by binding to NEK7, thereby inhibiting subsequent pyroptosis and osteoclastogenesis. Importantly, PIN alleviates inflammatory bone loss due to estrogen deficiency, reduces cranial bone destruction from local LPS injections, and improves survival in LPS‐induced septic mice. This study uncovers the specific mechanism behind PIN's potent anti‐inflammatory effects and identifies a new therapeutic target for NLRP3‐driven diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, The First Affiliated Hospital of Soochow University, No. 188 Shizi Street, Suzhou, Jiangsu, 215006, China.
- Department of Implant Dentistry, Suzhou Stomatological Hospital, Suzhou, Jiangsu, 215005, China.
- Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No.85 Wujin Road, Hongkou District, Shanghai, 200080, China.
- Department of Anesthesiology, Affiliated Hospital of Jiangsu University, 438 Jie Fang Road, Zhenjiang, Jiangsu, 212001, China.
- Department of Orthopedics, Hai'an People's Hospital, Hai'an, Jiangsu, 226000, China.
- Department of Spine Surgery, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, 210009, China.
ORCID-Profile: Liangliang Wang
Förderung
- National Natural Science Foundation of China
- Program of Suzhou Health Commission
- National and Local Engineering Laboratory of New Functional Polymer Materials
- Foundation of National Center for Translational Medicine
- Project of MOE Key Laboratory of Geriatric Diseases and Immunology
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
- Changzhou Sci&Tech Program
Zitieren
APA
Zhang, W., Wu, X., Li, W., Zhang, H., Wang, Y., Xu, J., Li, W., Qin, Y., Wu, Z., Ge, G., Lv, S., Mao, L., Wang, L., & Geng, D. (2025). Pinosylvin Inhibits Inflammatory and Osteoclastogenesis via NLRP3 Inflammasome. Advanced Science. https://doi.org/10.1002/advs.202501532
Vancouver
Zhang W, Wu X, Li W, Zhang H, Wang Y, Xu J, et al. Pinosylvin Inhibits Inflammatory and Osteoclastogenesis via NLRP3 Inflammasome. Advanced Science. 2025. doi:10.1002/advs.202501532
BibTeX
@article{Zhang2025,
author = {Zhang, Wei and Wu, Xiangbing and Li, Wenming and Zhang, Haifeng and Wang, Yijun and Xu, Jing and Li, Wenhao and Qin, Yi and Wu, Zebin and Ge, Gaoran and Lv, Shujun and Mao, Lu and Wang, Liangliang and Geng, Dechun},
title = {Pinosylvin Inhibits Inflammatory and Osteoclastogenesis via NLRP3 Inflammasome},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202501532}
}
EUVIMED